We had 35 people turn out for this last joint WPMC-ALT walk of the year. This was strictly a survey with no collecting for food. We mostly found fungi growing on wood with very little directly on the ground. The weather had a slight chill, but I had to remove my jacket during identification.
The instructions on the web site were wrong, so a few people went to the wrong side of the park. Richard Jacob picked up a couple. Identifier Sarah Banach was among the misdirected who eventually found us. She helped Richard and La Monte with identification.
Richard has been doing his homework, which includes microscopy and DNA barcoding, and tells us that the small orange eyelash cup we find is actually Scutellinia subhirtella, not S. setosa that we’ve been calling it for years.
The Stemonits splendens had lost enough spores that we could tell under a hand lens that the columnella did not extend all the way to the end of the sporangium. This allowed us to get a positive ID without microscopy.
Species list entered by La Monte H.P. Yarroll.
List of species found on the walk at Dead Man’s Hollow:
Arcyria denudata (Pink Carnival Candy Slime),
Armillaria gallica (Honey Mushroom),
Coprinus lagopides (),
Daedaleopsis confragosa (Thin-maze Flat Polypore),
Daldinia concentrica (Carbon Balls),
Datronia mollis (),
Diatrype stigma (),
Ganoderma lobatum (Soft Artist’s Conk),
Gloeoporus dichrous (),
Grifola frondosa (Hen of the Woods / Sheep Head),
Hapalopilus nidulans (Tender Nesting Polypore),
Hypoxylon multiforme (),
Irpex lacteus (Milk-white Toothed-Polypore),
Laetiporus sulphureus (Chicken Mushroom; Sulphur Shelf),
Lentinellus ursinus (),
Lenzites betulina (Multicolor Gill Polypore),
Multiclavula mucida (),
Neofavolus alveolaris (Hexagonal-pored Polypore),
Panellus stipticus (Luminescent Panellus, bitter oyster),
Phellinus gilvus (Mustard Yellow polypore),
Pleurotus ostreatus (Oyster Mushroom),
Pluteus cervinus (Deer mushroom),
Pycnoporus cinnabarinus (Cinnabar Red Polypore),
Scleroderma citrinum (Pigskin Poison Puffball),
Scutellinia scutellata (Reddish Eyelash Cup),
Scutellinia subhirtella (Orange Eyelash Cup),
Serpula lacrimans (Dry rot),
Stemonitis splendens (Chocolate Tube Slime),
Stereum complicatum (Crowded Parchment),
Stereum ostrea (False Turkey-tail),
Trametes gibbosa (Lumpy bracket),
Trametes hirsuta (),
Trametes versicolor (Turkey-tail),
Trichaptum biforme (Violet Toothed-Polypore),
Trichia favoginea (),
Xylaria cornu-damae (),
Xylaria cubensis (),
Xylaria polymorpha (Dead Man’s Fingers),
Xylobolus frustulatus (Ceramic Parchment)
Species not currently on clubs life list:
Lepiota sp. (Cap 10cm edge to edge, gills white free close, no annulus, base of stalk missing, on wood)
Hi all, I just want to ask if someone ever tried using shrooms or truffles for medical purposes? I was reading some articles about this magic truffles and shrooms before engaging my self for the first time. Like this one from:https://www.trufflemagic.com/blog/psilocybe-serbica/ .They say that it has a very potent effect on the brain and hallucination. Unlike marijuana does it have any medical use? In one article that I’ve read magic truffles or shrooms compaired to synthetic drugs are very alarming. Also magic mushroom are use on reducing the symptoms of obsessive-compulsive disorder and anxiety. It can also help people to quit smoking and alcohol addiction. Some studies also suggest the property of magic shrooms/truffles can be useful for cancer patients. I would really want to hear other insights regarding this new possible alternative meds. Thanks
Psilocybin, the active compound in “magic mushrooms”, has been shown to have medical uses in the treatment of psychiatric conditions such as anxiety, depression, and substance abuse. A review of recent studies was published early this year. Sorry, I don’t have access to the full text of the review. However, eating magic truffles or shrooms recreationally is not the same as undergoing therapeutic treatment with a trained psychotherapist in a controlled environment. The current studies have been small but the results have been promising – more work needs to be done. Psilocybin is still listed as a schedule I drug with no currently accepted medical use and a high potential for abuse. Until the FDA lowers the schedule for psilocybin academic and medical research will be limited. Look for changes to the schedule in the next few years followed by an increase in the number and size of studies.